Orgenesis Inc (ORGS)

NASDAQ
2.890
-0.220(-7.07%)
  • Volume:
    65,430
  • Bid/Ask:
    2.880/3.240
  • Day's Range:
    2.880 - 3.110

ORGS Overview

Prev. Close
3.11
Day's Range
2.88-3.11
Revenue
30.91M
Open
3.11
52 wk Range
2.88-8.3
EPS
-2.69
Volume
65,430
Market Cap
69.4M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
61,734
P/E Ratio
-
Beta
1.22
1-Year Change
-29.32%
Shares Outstanding
24,013,186
Next Earnings Date
Mar 08, 2022
What is your sentiment on Orgenesis Inc?
or
Market is currently closed. Voting is open during market hours.

Orgenesis Inc Company Profile

Employees
111

Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company’s POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.